Clear, approachable education about peptides, compounds, biological pathways, and emerging areas of scientific research.
INVESTIGATIONAL — IN CLINICAL TRIALS
A triple hormone-receptor agonist in Phase 3 clinical trials for obesity and related metabolic conditions.
READ THE RESEARCH →
FDA-APPROVED FOR A SPECIFIC USE
A dual GLP-1/GIP receptor agonist, FDA-approved under specific brand names for type 2 diabetes and chronic weight management.
READ THE RESEARCH →
NOT FDA-APPROVED FOR ANY USE
A synthetic peptide fragment studied in preclinical models for gut and tissue-healing pathways.
READ THE RESEARCH →
NOT FDA-APPROVED FOR ANY USE
A naturally occurring copper peptide studied in dermatological and tissue-remodeling research.
READ THE RESEARCH →
NOT FDA-APPROVED FOR ANY USE
A naturally occurring coenzyme central to cellular energy metabolism, studied in the context of aging and metabolic health.
READ THE RESEARCH →
FDA-APPROVED FOR A SPECIFIC USE
A GHRH analog FDA-approved under the brand name Egrifta for reducing excess abdominal fat in HIV-associated lipodystrophy.
READ THE RESEARCH →Education. Insights. A brighter tomorrow.
Scientific information can be approachable without overstating what the evidence shows. We present research clearly while distinguishing experimental findings from established medical evidence.
MORE ABOUT PEPPY